patent hearing cause of weakness | ACAD Message Board Posts


ACADIA Pharmaceuticals Inc.

  ACAD website

ACAD   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  19706 of 19725  at  9/28/2023 2:38:18 PM  by

rational1_2000


patent hearing cause of weakness

  • Acadia Pharmaceuticals (NASDAQ:ACAD) dropped 14% a day after a patent hearing regaring its drug Nuplazid, which is used to treat Parkinson's disease.
  • Acadia (ACAD) filed separate lawsuits last October alleging that copies of Nuplazid infringed a patent, including a lawsuit against MSN Laboratories.
  • At least one expert that follows the cases said that, in their opinion, it appeared that MSN had won the hearing on Wednesday, according to traders.
  • Developing a story...

https://seekingalpha.com/news/4016373-acadia-pharmaceuticals-fall-after-patent-hearing-in-dispute-with-msn


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 4  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board




Financial Market Data provided by
.
Loading...